MedReleaf Study

Releaf for Veterans, an observational study on veteran chronic pain

CA Clinics is excited to be a part of Medreleaf Australia’s Releaf for Veterans study, an extension of the CA Clinics Observational Study (CACOS) run by Applied Cannabis Research.

The Releaf for Veterans study is set up to explore the impacts of medicinal cannabis treatments on Australian veterans, with a goal to improving veteran health and broaden pathways to supporting services. This would have a particular focus on collecting data for the management of chronic pain conditions using MedReleaf Australia products.

Australia’s veteran patients, including currently recruited CA Clinics patients who are 18 and older are eligible to join the study.

*Medication may be eligible for DVA funding but patients will still be required to pay pharmacy dispensing fees and any applicable postage costs. Normal clinical consultation fees apply.

Am I suitable for this medicinal cannabis study?

Patients aged 18 and older who are approved for a prescription of a MedReleaf Australia product through a CA Clinics doctor will be eligible to enrol in the study.

For more information please see the detailed Participant Information and Consent Form.

If you are interested in finding out more please contact CA Clinics at 1300 991 477.